Long-standing COVID-19 infection outcomes like cognitive & functional, and acute neurological complexities are less discussed, presented, and documented substantially.
It includes breathing & gastrointestinal difficulties, sleep disturbances, frequent headaches, anxiety episodes, depressed feelings, attention impairment & loss of memory.
In inappropriately handled long-lasting hospitalized patients warning consequences of chronic stage causes mental challenges & “brain fog”.
Long COVID care demands the development of patient-centered preventive measures, rehabilitation techniques & clinical management procedures. Simultaneously detailed analysis and understanding of the prevalence, risk factors, and pathophysiology of brain fog is crucial.
In post-acute sequelae, COVID-19 patients, structural & functional abnormalities of frontal, temporal, and limbic areas develop.
Olfactory network structural changes including prefrontal structures, corpus callosum and insula involvement, temporal lobe, basal ganglia, brainstem, and cerebellum are the most reported.
The cognitive disturbance duration depends on the severity of cognitive damage.
Brain fog is a descriptive terminology & is explained by the patients as a diverse bunch of intellectual function-related complications comprising trouble in thinking, remembering, and reasoning that interferes with daily functioning and instigates neuropsychological dysfunctions.
As per the World Health Organization (WHO), brain fog is defined as an informal term for a common complaint of intellectual functions among patients with post-acute COVID-19. Impairment of cognitive function, confusion, short-term memory loss, dizziness, and inability to concentrate come under brain fog.
It is a common characteristic in healing or recovering patients affecting their higher cognitive or “executive” function.
Brain fog requires serious attention from medical practitioners in employing its instructive & protective procedures.
Virus-induced long-standing & neurodegeneration cognitive impairment denotes the hippocampal distribution of microglial activation, systemic inflammation & sepsis.
Severe acute intensive care patients of COVID-19 develop hypoxia, vascular nerve cell injury & endothelial dysfunction associated with microvascular damage. Concomitantly immunological dysregulation, chronic inflammation & peripheral organ dysfunction occur. Cerebral white matter becomes vulnerable to ischaemic injury, cerebral hypoperfusion, amyloid-beta rapid accumulation, and TAR DNA binding protein-43 pathology.
There are also chances of systemic inflammatory injury & abnormalities, blood-brain barrier permeability increase & disturbance in tight junction proteins associated with brain parenchyma.
Cognition controlling the hippocampus, temporal lobe, and thalamus gets affected by thrombotic and inflammatory cascade leading to capillary occlusion, and ischemia.
Suitable intervention strategies, scientific community-based future studies & trials can reduce long-lasting COVID-19-related cognitive diminishing symptoms & their effects.
Read more such content on @ Hidoc Dr | Medical Learning App for Doctors
1.
According to the Lancet, proton beam therapy may shorten the course of treatment for patients with breast cancer.
2.
If CD19 CAR T-Cell Therapy Fails in Lymphoma, Try a CD22 Version
3.
CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma
4.
"We Caught It Early": Advantage or Disadvantage?
5.
Waist circumference outshines BMI as obesity-related cancer risk marker in men, but not women
1.
How Should We Approach Solid Pseudopapillary Neoplasm of the Pancreas with Hepatic Metastases?
2.
Screening for Early Changes in Hematopoietic Reserve Among High-Risk Populations
3.
Colorectal Cancer Uncovered: CME, Case Studies, and Clinical Strategies
4.
Precision Oncology Through Spatial Tumor Phenotyping
5.
Fatigue Rehabilitation in Blood Disorders
1.
International Conference on Oncology, Cancer Prevention and Public Health
2.
International Conference on Cancer Nursing and Rehabilitation Strategies
3.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
4.
International Conference on Innovations in Critical Care for Oncology and Cardiology
5.
International Symposium on Oncology, Cardiology and Critical Care Innovations
1.
Guideline Recommendations of Lorlatinib as First-Line Treatment for ALK+ NSCLC
2.
Current Scenario of Cancer- Q&A Session to Close the Gap Part II
3.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part I
4.
Managing Fatigue During Cancer Treatment
5.
When Unexplained Bruising May Require Blood Testing
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation